First license issued to grow, research MMJ in Australia

Women, minority execs show few gains in U.S. cannabis industry, according to the latest data from the MJBiz Diversity, Inclusion and Equity Report. Get your copy here.

Cann Group has received the first federal government license to grow medical cannabis in Australia and has submitted an application for a cultivation permit.

The new license permits the privately held company to legally grow medical marijuana and conduct research on how to use cannabis for medicinal purposes, according to Business Insider Australia.

“The license allows us to apply for a permit to progress our research and development programs, which are particularly focused on the breeding, cultivation, extraction and characterization of cannabinoids,” Cann Group chairman Allan McCallum told Business Insider.

Cann Group also has filed paperwork with federal regulators to receive a cultivation license and said it was confident it would get the green light.

The licensing comes after Australia legalized MMJ last year for patients with chronic or painful illnesses.

Australia won’t be using the dispensary model that other nations employ. Pharmacies will sell to MMJ patients instead.

Under federal law, patients can have access only to MMJ that has been approved under the Therapeutic Goods Act and relevant state and territory legislation, Business Insider reported.

Cann Group also does business in New Zealand and has partnered with U.S. edibles company Dixie Brands.